Affinity Asset Advisors, LLC Renovacor, Inc. Transaction History

Affinity Asset Advisors, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	BUY	$4.02 - $8.23 $299,449 - $613,052	74,490 Added 59.59%	199,490 $846,000
Q4 2021 Feb 11, 2022	BUY	$6.99 - $9.39 $69,900 - $93,900	10,000 Added 8.7%	125,000 $963,000
Q3 2021 Nov 12, 2021	BUY	$7.73 - $10.65 $888,950 - $1.22 Million	115,000 New	115,000 $1.04 Million

Ticker RCOR
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,267,700
Description
Renovacor, Inc., a biotechnology company, focuses on delivering various precision therapies to enhance the lives of patients and families battling genetically-driven cardiovascular and mechanistically-related diseases. It primarily focuses on the treatment of BCL2-associated athanogene 3 (BAG3) mutation-associated dilated cardiomyopathy (DCM). T...

Get notified when there are updates to the investment portfolio of Affinity Asset Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Affinity Asset Advisors, LLC with notifications on news.